Does SORAFENIB Cause Renal cell carcinoma? 118 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 118 reports of Renal cell carcinoma have been filed in association with SORAFENIB (sorafenib). This represents 1.1% of all adverse event reports for SORAFENIB.
118
Reports of Renal cell carcinoma with SORAFENIB
1.1%
of all SORAFENIB reports
31
Deaths
23
Hospitalizations
How Dangerous Is Renal cell carcinoma From SORAFENIB?
Of the 118 reports, 31 (26.3%) resulted in death, 23 (19.5%) required hospitalization, and 3 (2.5%) were considered life-threatening.
Is Renal cell carcinoma Listed in the Official Label?
Yes, Renal cell carcinoma is listed as a known adverse reaction in the official FDA drug label for SORAFENIB.
What Other Side Effects Does SORAFENIB Cause?
Hepatocellular carcinoma (1,665)
Diarrhoea (1,611)
Off label use (1,587)
Fatigue (1,041)
Palmar-plantar erythrodysaesthesia syndrome (1,040)
Decreased appetite (906)
Death (904)
Asthenia (777)
Nausea (716)
Rash (613)
What Other Drugs Cause Renal cell carcinoma?
CABOZANTINIB S-MALATE (451)
SUNITINIB MALATE (361)
PAZOPANIB (244)
AXITINIB (154)
RANITIDINE (143)
EVEROLIMUS (130)
METHOTREXATE (116)
ADALIMUMAB (105)
PREDNISONE (101)
TACROLIMUS (98)
Which SORAFENIB Alternatives Have Lower Renal cell carcinoma Risk?
SORAFENIB vs SORGHUM HALEPENSE POLLEN
SORAFENIB vs SOTAGLIFLOZIN
SORAFENIB vs SOTALOL
SORAFENIB vs SOTATERCEPT
SORAFENIB vs SOTATERCEPT-CSRK